Deutsche Bank’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$482K Sell
27,582
-6,872
-20% -$136K ﹤0.01% 2587
2025
Q4
$676K Sell
34,454
-1,667
-5% -$34.6K ﹤0.01% 2401
2025
Q3
$995K Hold
36,121
﹤0.01% 2171
2025
Q2
$1.1M Buy
36,121
+964
+3% +$27.4K ﹤0.01% 2037
2025
Q1
$948K Hold
35,157
﹤0.01% 2179
2024
Q4
$1.26M Hold
35,157
﹤0.01% 2120
2024
Q3
$1.33M Buy
35,157
+1,925
+6% +$79.1K ﹤0.01% 1985
2024
Q2
$1.5M Sell
33,232
-751
-2% -$34.6K ﹤0.01% 1780
2024
Q1
$1.65M Hold
33,983
﹤0.01% 1764
2023
Q4
$1.82M Buy
33,983
+27,320
+410% +$1.38M ﹤0.01% 1724
2023
Q3
$391K Sell
6,663
-26,772
-80% -$1.67M ﹤0.01% 2328
2023
Q2
$2.11M Sell
33,435
-2,613
-7% -$166K ﹤0.01% 1592
2023
Q1
$2.27M Buy
36,048
+2,567
+8% +$153K ﹤0.01% 1618
2022
Q4
$1.78M Buy
33,481
+800
+2% +$43.3K ﹤0.01% 1719
2022
Q3
$1.83M Sell
32,681
-1,439
-4% -$95.1K ﹤0.01% 1666
2022
Q2
$2.47M Sell
34,120
-1,339
-4% -$99.7K ﹤0.01% 1649
2022
Q1
$2.82M Sell
35,459
-2,241
-6% -$202K ﹤0.01% 1690
2021
Q4
$3.82M Sell
37,700
-45,038
-54% -$4.49M ﹤0.01% 1601
2021
Q3
$7.63M Sell
82,738
-352
-0.4% -$33.9K ﹤0.01% 1278
2021
Q2
$8.51M Sell
83,090
-2,503
-3% -$251K ﹤0.01% 1254
2021
Q1
$8.35M Buy
85,593
+39,871
+87% +$3.63M ﹤0.01% 1286
2020
Q4
$3.52M Buy
45,722
+20,464
+81% +$1.58M ﹤0.01% 1556
2020
Q3
$1.86M Sell
25,258
-6,342
-20% -$509K ﹤0.01% 1793
2020
Q2
$2.32M Sell
31,600
-7,417
-19% -$582K ﹤0.01% 1710
2020
Q1
$2.25M Buy
39,017
+29,023
+290% +$2.02M ﹤0.01% 1639
2019
Q4
$784K Sell
9,994
-79,378
-89% -$5.85M ﹤0.01% 2495
2019
Q3
$6.11M Sell
89,372
-118,792
-57% -$7.98M ﹤0.01% 1279
2019
Q2
$16.5M Buy
208,164
+106,585
+105% +$8.45M 0.01% 1056
2019
Q1
$8.52M Buy
101,579
+8,293
+9% +$866K 0.01% 1489
2018
Q4
$11M Sell
93,286
-192,024
-67% -$22.2M 0.01% 1242
2018
Q3
$34.4M Buy
285,310
+77,571
+37% +$9.63M 0.02% 833
2018
Q2
$24M Buy
207,739
+42,968
+26% +$4.7M 0.01% 1069
2018
Q1
$14.2M Buy
164,771
+21,859
+15% +$1.69M 0.01% 1348
2017
Q4
$10.6M Buy
142,912
+19,091
+15% +$1.28M 0.01% 1453
2017
Q3
$7.14M Sell
123,821
-79,249
-39% -$4.68M ﹤0.01% 1675
2017
Q2
$13M Buy
203,070
+111,840
+123% +$6.89M 0.01% 1205
2017
Q1
$5.25M Buy
91,230
+17,189
+23% +$1.03M ﹤0.01% 1643
2016
Q4
$4.53M Sell
74,041
-69,421
-48% -$4.52M ﹤0.01% 1725
2016
Q3
$9.92M Sell
143,462
-17,370
-11% -$1.15M 0.01% 1316
2016
Q2
$8.96M Buy
160,832
+98,224
+157% +$5.92M 0.01% 1373
2016
Q1
$3.8M Sell
62,608
-31,212
-33% -$1.84M ﹤0.01% 1939
2015
Q4
$5.99M Sell
93,820
-197,322
-68% -$12.8M ﹤0.01% 1672
2015
Q3
$19.5M Buy
291,142
+153,824
+112% +$10.9M 0.02% 898
2015
Q2
$9.38M Sell
137,318
-57,714
-30% -$3.66M 0.01% 1385
2015
Q1
$10.8M Sell
195,032
-6,964
-3% -$357K 0.01% 1275
2014
Q4
$10.4M Buy
201,996
+64,564
+47% +$3.17M 0.01% 1403
2014
Q3
$5.06M Sell
137,432
-40,034
-23% -$1.44M ﹤0.01% 1821
2014
Q2
$6.93M Sell
177,466
-29,762
-14% -$1.1M ﹤0.01% 1591
2014
Q1
$7.8M Buy
207,228
+43,660
+27% +$1.52M 0.01% 1506
2013
Q4
$6.18M Sell
163,568
-9,116
-5% -$349K ﹤0.01% 1621
2013
Q3
$7.49M Buy
172,684
+131,352
+318% +$5.27M 0.01% 1522
2013
Q2
$1.49M Buy
+41,332
New +$1.26M ﹤0.01% 2417

Other funds holding USNA

Deutsche Bank's USNA Position: Q1 2026 in Review

Deutsche Bank reduced its Usana Health Sciences (USNA) stake by 20% in Q1 2026, selling an estimated $136K and leaving 27,582 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #2587.

Deutsche Bank first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.4M in Q3 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Deutsche Bank held 27,582 shares of Usana Health Sciences worth $482K as of Q1 2026.
  • Deutsche Bank sold 6,872 Usana Health Sciences shares in Q1 2026, an estimated $136K.
  • Usana Health Sciences made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2587 holding.
  • Deutsche Bank first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Usana Health Sciences position peaked at $34.4M in Q3 2018.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.